Novel insights into the cellular basis of atrial fibrillation

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 7, 2010, Pages 907-916

  Patel, Vickas V ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

atrial fibrillation; autonomic tone; ectopic foci; melanocyte like cells

Indexed keywords

ADRENERGIC RECEPTOR; MUSCARINIC RECEPTOR; DOPACHROME ISOMERASE; ISOMERASE;

CELL POPULATION; CYTOLOGY; EXTRASYSTOLE; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; MELANOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PULMONARY VEIN; REVIEW; SINUS NODE; ANIMAL; ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM; DEFICIENCY; ELECTROPHYSIOLOGY; ENZYMOLOGY; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; HEART MUSCLE; METABOLISM; PHYSIOLOGY; THORAX; VASCULARIZATION; VEIN;

ANIMALS; ATRIAL FIBRILLATION; AUTONOMIC NERVOUS SYSTEM; ELECTROPHYSIOLOGICAL PHENOMENA; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HEART ATRIA; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MELANOCYTES; MYOCARDIUM; MYOCYTES, CARDIAC; PULMONARY VEINS; SINOATRIAL NODE; THORAX; VEINS;

EID: 77954484960     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.10.54     Document Type: Review

References (57)

1. Carnes CA, Chung MK, Nakayama T et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 89, E32-E38 (2001).
2. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 108, 711-716 (2003).
3. Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 14, 666-672 (2003).
4. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155, 469-473 (1995).
5. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. J. Am. Med. Assoc. 254, 3449-3453 (1985).
6. Levy S, Maarek M, Coumel P et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 99, 3028-3035 (1999).
7. Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339, 659-666 (1998).
8. Cappato R, Calkins H, Chen SA et al. Up-dated worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3, 32-38 (2010).
9. Dhruvakumar S, Gerstenfeld EP. Complications associated with catheter ablation of atrial fibrillation. Minerva Cardioangiol. 55, 353-368 (2007).
10. Sauer WH, McKernan ML, Lin D, Gerstenfeld EP, Callans DJ, Marchlinski FE. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 3, 1024-1028 (2006). (Pubitemid 44283690)
11. Bellandi F, Simonetti I, Leoncini M et al. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. Am. J. Cardiol. 88(6), 640-645 (2001).
12. Kochiadakis GE, Marketou ME, Igoumenidis NE et al. Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? Pacing Clin. Electrophysiol. 23, 1883-1887 (2000).
13. Singh BN, Singh SN, Reda DJ et al. Amiodarone versus sotalol for atrial fibrillation. N. Engl J. Med. 352(18), 1861-1872 (2005).
14. Levin MD, Lu MM, Peterenko NB et al. Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers. J. Clin. Invest. 119, 3420-3436 (2009).
15. Chen SA, Hsieh MH, Tai TC et al. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins. Circulation 100, 1879-1886 (1999).
16. Pappone C, Rosanio S, Oreto G et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach. Circulation 102, 2619-2628 (2000).
17. Oral H, Knight BP, Tada H et al. Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation. Circulation 105, 1077-1081 (2002). (Pubitemid 34212617)
18. Hirose M, Laurita KR. Calcium-mediated triggered activity is an underlying cellular mechanism of ectopy originating from the pulmonary vein in dogs. Am. J. Physiol. Heart Circ. Physiol. 292, H1861-H1867 (2007).
19. Patterson E, Po S, Scherlag BJ, Lazzara R. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2, 624-631 (2005).
20. Chou C-C, Nihei M, Zhou S et al. Intracellular calcium dynamics and anisotropic reentry in isolated canine pulmonary veins and left atrium. Circulation 111, 2889-2897 (2005).
21. Arora R, Verheule S, Scott L et al. Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping. Circulation 107, 1816-1821 (2003).
22. Seol CA, Kim J, Kim WT et al. Simulation of spontaneous action potentials of cardiomyocytes in pulmonary veins of rabbits. Prog. Biophys. Mol. Biol. 96, 132-151 (2008).
23. Wongcharoen W, Chen YC, Chen YJ et al. Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity. Cardiovasc. Res. 70, 497-508 (2006).
24. Melnyk P, Ehrlich JR, Pourrier M, Villeneuve L, Cha TJ, Nattel S. Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium. Circulation 65, 104-116 (2005).
25. Ehrlich JR, Cha TJ, Zhang L et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties. J. Physiol. 551, 801-813 (2003).
26. Tan AY, Chen P-S, Chen LS, Fishbein MC. Autonomic nerves in pulmonary veins. Heart Rhythm 4, S57-S60 (2007).
27. Morel E, Meyronet D, Thivolet-Bejuy F, Chevalier P. Identification and distribution of interstitial Cajal cells in human pulmonary veins. Heart Rhythm 5, 1063-1067 (2008).
28. Gherghiceanu M, Hinescu ME, Andrei F et al. Interstitial Cajal-like cells (ICLC) in myocardial sleeves of human pulmonary veins. J. Cell Mol. Med. 12, 1777-1781 (2008).
29. Perez-Lugones A, McMahon JT, Ratliff NB et al. Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 14, 803-809 (2003).
30. Gerstenfeld EP, Callans DJ, Dixit S, Zado E, Marchlinski FE. Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies. J. Cardiovasc. Electrophysiol. 14, 685-690 (2003).
31. Kistler PM, Roberts-Thomson KC, Haqqani HM et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J. Am. Coll. Cardiol. 48, 1010-1017 (2006).
32. Hillock RJ, Kalman JM, Roberts-Thomson KC, Haqqani H, Sparks PB. Multiple focal atrial tachycardias in a healthy adult population: characterization and description of successful radiofrequency ablation. Heart Rhythm 4, 435-438 (2007).
33. Kistler PM, Sanders P, Hussin A et al. Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J. Am. Coll. Cardiol. 41, 2212-2219 (2003).
34. Lee HT, Hennig GW, Fleming NW et al. Septal interstitial cells of Cajal conduct pacemaker activity to excite muscle bundles in human jejunum. Gastroenterology 133, 907-917 (2007).
35. Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 111, 492-515 (1996).
36. Dudley SC Jr, Hoch NE, McCann LA et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112, 1266-1273 (2005).
37. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J. Gen. Physiol. 108, 277-293 (1996).
38. Wang W, Ma J, Zhang P, Luo A. Redox reaction modulates transient and persistent sodium current during hypoxia in guinea pig ventricular myocytes. Pflugers Arch. 454, 461-475 (2007).
39. Lu Z, Abe J, Taunton J et al. Reactive oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac repolarization through inhibiting outward K+ channel activity. Circ. Res. 103, 269-278 (2008).
40. Cable J, Jackson IJ, Steel KP. Mutations at the W locus affect survival of neural crestderived melanocytes in the mouse. Mech. Dev. 50, 139-150 (1995).
41. Steel KP, Davidson DR, Jackson IJ. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development 115, 1111-1119 (1992).
42. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335, 88-89 (1988).
43. Geissler EN, Ryan MA, Housman DE. The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 7, 185-192 (1988).
44. Ardell JL. Structure and function of the mammalian intrinsic cardiac neurons. In: Neurocardiology. Armour JA, Ardell JL (Eds). Oxford University Press, NY, USA (1994).
45. Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat. Rec. 247, 289-298 (1997).
46. Scherlag BJ, Yamanashi WS, Patel U, Lazzara R, Jackman WM. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J. Am. Coll. Cardiol. 45, 1575-1580 (2005).
47. Lin J, Scherlag BJ, Lu Z et al. Inducibility of atrial and ventricular arrhythmias along the ligament of Marshall: role of autonomic factors. J. Cardiovasc. Electrophysiol. 19, 955-962 (2008).
48. Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J. Cardiovasc. Electrophysiol. 12, 285-291 (2001).
49. Lu Z, Scherlag BJ, Lin J et al. Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins: evidence by ablation of ganglionated plexi. Cardiovasc. Res. 84, 245-252 (2009).
50. Coumel P, Attuel P, Lavallee J, Flammang D, Leclercq JF, Slama R. The atrial arrhythmia syndrome of vagal origin. Arch. Mal. Coeur Vaiss. 71, 645-656 (1978).
51. Doshi RN, Wu T-J, Yashima M et al. Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia. Circulation 100, 876-883 (1999).
52. Coumel P. Paroxysmal atrial fibrillation: a disorder of autonomic tone? Eur. Heart J. 15, 9-16 (1994). (Pubitemid 24158556)
53. Oral H, Chugh A, Scharf C et al. Pulmonary vein isolation for vagotonic, adrenergic, and random episodes of paroxysmal atrial fibrillation. J. Cardiovasc. Electrophysiol. 15, 402-408 (2004).
54. Pappone C, Santinelli V, Manguso F et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109, 327-334 (2004).
55. Lemola K, Chartier D, Yeh YH et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Circulation 117, 470-477 (2008).
56. Patterson E, Lazzara R, Szabo B et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J. Am. Coll. Cardiol. 47, 1196-1206 (2006).
57. Genade S, Genis A, Ytehus K, Huisamen B, Lochner A. Melatonin receptor-mediated protection against myocardial ischaemia/ reperfusion injury: role of its anti-adrenergic actions. J. Pineal Res. 45, 449-458 (2008).